TRAZADONE: Man Pleads Guilty to Homicide After Baby Dies on Antidepressant

TRAZADONE: Man Pleads Guilty to Homicide After Baby Dies on Antidepressant

By Ann Blake-Tracy on December 14, 2014

Gene Richins

Gene Richins, Sandy, UT

For years in Utah Prozac was known as “Sandy Candy” due to the extremely high use of Prozac in that city. Antidepressants continue to flow there even though this article does not say whether or not Gene himself might have been on one as well thus further complicating this case. What we do know happened is that while caring for his own baby and his girlfriend’s baby woke up.

The girlfriend had earlier taken her Trazadone and Xanax to go to sleep and was too sedated to be awakened by the baby’s cries. The boyfriend gave the baby some of his own baby’s prescription Tylenol mixed with some Trazadone to get her to go back to sleep. She was found unresponsive the following morning and pronounced dead.

This young man was arrested and charged with homicide in the death and his bail set at $1 Million! (Obviously another story there as to why on earth the would be a need to set a $1 Million bail in this case!)

But what is so very dangerous about Trazadone (Deseryl) is that too many are told that it is a sleeping pill when instead it is an antidepressant – a powerful antidepressant. In fact it is the same antidepressant that the Navy yard shooter was taking when he went on his shooting spree last year.

Had this young man known any of this about Trazadone (Deseryl) perhaps he would not have given this drug to the baby. Without question there needs to be stricter labeling on this drug and more disclosure to patients about the dangers.

jonathan Midlo

Jonathan Midlo

Jonathan Midlo, a young man in MN, knew his body could not handle the reactions from antidepressants and specifically told doctors to never give them to him because of that. But after several days of pushing long hard hours at work he was having trouble sleeping and saw his sister’s prescription for Trazadone in the medicine cabinet which said to take it for sleep. After taking it he became very agitated and a few hours later ended up taking his own life. This happened even though he was NOT depressed and was very happily engaged to be married soon…not in line with suicidal planning in any way. Clearly a toxic reaction to the drug. Had the bottle indicated it was an antidepressant he would have known not to take it.

To learn more about what happened in Johnathan’s case go to http://www.jonnyslaw.org/

ORIGINAL ARTICLE: http://www.deseretnews.com/article/865617564/Sandy-man-pleads-guilty-in-death-of-baby-who-had-drugs-in-body.html?pg=all

http://www.deseretnews.com/article/865599078/Sandy-man-charged-in-death-of-girlfriends-infant-daughter.html?pg=all

Posted in Psychiatric drugs problems | Tagged , , , , | Leave a comment

BIPOLAR JUDGE: Board Questions Judge’s Mental Health After Courtroom Rant

judgebrim

BIPOLAR JUDGE: Board Questions Judge’s Mental Health After Courtroom Rant

By Ann Blake-Tracy on December 11, 2014

Judge Cynthia Brim

Judge Cynthia Brim removed from the bench
Illinois Courts Commission says unmedicated Cynthia Brim isn’t fit to be a judge

This case will give you a glimpse of how insane the entire judicial system is because of these drugs. Keep in mind that although in a case preparing to go to court we have the right to ask questions about the jury being on antidepressants or having close family members on the drugs, etc. we do not have that right to ask the same about judges!

Make sense to you?

No?

Me either, never has!

I would want to know if the judge is on an antidepressant where they are ruling in a criminal case involving an antidepressant. I would also like to know if they have any financial ties, investments, etc. in an antidepressant as well!

We have way too many medicated judges, medicated attorneys, medicated law enforcement officers, medicated social workers who can make decisions similar to judges. We even have the case of a federal judge in Kansas on antidepressants who killed his wife and himself. Check out our database of cases again to see more or find that one: http://www.ssristories.NET And I got a report about three years ago of several federal judges who had committed suicide on antidepressants.

Anyway take a look at the case of this judge…..

Judge Cynthia Brim has been suspended, but collecting her $182,000 salary. She told the commission in March she is ready to return to work. Her statement, “I can serve as a judge with full capability as long as I continue to take medication as prescribed.”

She has been hospitalized for psychiatric episodes five times since becoming a judge in 1994! She also acknowledged she hadn’t taken her medications or sought treatment for two years before her latest breakdown. Which means she likely came off her medications too rapidly and it triggered another manic episode later for her.

The ruling said Brim’s mental issues interfered with her ability to do the job and that she “bears responsibility for not seeking the necessary treatment.” So she’s out.

So rather than remove her from the bench because she is taking antidepressants, which likely made her bipolar in the first place, they are removing her because she is NOT drugged!!! If this is not evidence of just how messed up our society is, I don’t know what is!

ORIGINAL ARTICLES: http://articles.chicagotribune.com/2014-05-10/opinion/ct-judge-cynthia-brim-edit-0510-20140510_1_judge-brim-illinois-courts-commission-supervising-judge

State Board to Decide if Cook County Judge is Mentally Competent to Sit

See more at: http://www.jdjournal.com/2013/08/14/state-board-to-decided-if-cook-county-judge-is-mentally-competent-to-sit/#sthash.LqFh0NON.dpuf

Posted in Psychiatric drugs problems | Tagged , | Leave a comment

AMERICA’S MOST POPULAR DRUG IS THE ATYPICAL ANTIPSYCHOTIC ABILIFY

Abilify_bottle

AMERICA’S MOST POPULAR DRUG IS THE ATYPICAL ANTIPSYCHOTIC ABILIFY

By Ann Blake-Tracy on December 11, 2014

Martha Rosenberg

Meet one of our newest members to join our International Coalition For Drug Awareness Facebook group – investigative reporter Martha Rosenberg.

For those of you new to this battle and unaware of the history of this battle or those who have been involved since the beginning to pave the way you need to know that Martha is an incredible reporter who has been writing about the antidepressants and atypical antipsychotics for many years now. In fact she has written some of the most hard hitting articles on this issue! An example of a recent one is posted below. She has been published widely.

We want to welcome her and thank her publicly for her tireless work in educating the public about these very dangerous drugs!

The following article was emailed to me but originally appeared in Alternet. (Please always keep in mind in learning about the atypical antipsychotics that they too are serotonergic drugs and technically should NOT be used with an antidepressant even though Abilify promotes itself as an add-on drug to antidepressant treatment!!!!!) I would encourage all of you to Google Martha Rosenberg and read and share her information far and wide!

THE MOST POPULAR DRUG IN AMERICA IS AN ANTIPSYCHOTIC — AND NO ONE REALLY KNOWS HOW IT WORKS

MARTHA ROSENBERG, ALTERNET
16 NOV 2014 AT 20:58 ET

Does anyone remember Thorazine? It was an antipsychotic given to mentally ill people, often in institutions, that was so sedating, it gave rise to the term “Thorazine shuffle.” Ads for Thorazine in medical journals, before drugs were advertised directly to patients, showed Aunt Hattie in a hospital gown, zoned out but causing no trouble to herself or anyone else. No wonder Thorazine and related drugs Haldol, Mellaril and Stelazine were called chemical straitjackets.

But Thorazine and similar drugs became close to obsolete in 1993 when a second generation of antipsychotics which included Risperdal, Zyprexa, Seroquel, Geodon and Abilify came online. Called “atypical” antipsychotics, the drugs seemed to have fewer side effects than their predecessors like dry mouth, constipation and the stigmatizing and permanent facial tics known as TD or tardive dyskinesia. (In actuality, they were similar.) More importantly, the drugs were obscenely expensive: 100 tablets of Seroquel cost as much as $2,000, Zyprexa, $1,680 and Abilify $1,644.

One drug that is a close cousin of Thorazine, Abilify, is currently the top-selling of all prescription drugs in the U.S. marketed as a supplement to antidepressant drugs, reports the Daily Beast. Not only is it amazing that an antipsychotic is outselling all other drugs, no one even knows how it works to relieve depression, writes Jay Michaelson. The standardized United States Product Insert says Abilify’s method of action is “unknown” but it likely “balances” brain’s neurotransmitters. But critics say antipsychotics don’t treat anything at all, but zone people out and produce oblivion. They also say there is a concerning rise in the prescription of antipsychotics for routine complaints like insomnia.

They are right. With new names and prices and despite their unknown methods of action, Pharma marketers have devised ways to market drugs like Abilify to the whole population, not just people with severe mental illness. Only one percent of the population, after all, has schizophrenia and only 2.5 percent has bipolar disorder. Thanks to these marketing ploys, Risperdal was the seventh best-selling drug in the world until it went off patent and Abilify currently rules.

Here are some of the ways Big Pharma made antipsychotics everyday drugs.

Approval Creep

Everyone has heard of “mission creep.” In the pharmaceutical world, approval creep means getting the FDA to approve a drug for one thing and pushing a lot of other drug approvals through on the coattails of the first one. Though the atypical antipsychotics were originally drugs for schizophrenia, soon there was a dazzling array of new uses.

Seroquel was first approved in 1997 for schizophrenia but subsequently approved for bipolar disorder, psychiatric conditions in children and finally as an add-on drug for depression like Abilify. The depression “market” is so huge, Seroquel’s last approval allowed the former schizophrenia drug to make $5.3 billion a year before it went off patent. But before the add-on approval, AstraZeneca, which makes Seroquel, ran a sleazy campaign to convince depressed people they were really “bipolar.” Ads showed an enraged woman screaming into the phone, her face contorted, her teeth clenched. Is this you, asked the ads? Your depression may really be bipolar disorder, warned the ad.

Sometimes the indication creep is under the radar. After heated FDA hearings in 2009 about extending Zyprexa, Seroquel and Geodon uses for kids–Pfizer and AstraZeneca slides showed that kids died in clinical trials–the uses were added by the FDA but never announced. They were slipped into the record right before Christmas, when no news breaks, and recorded as “label changes.” Sneaky.

And there is another “creep” which is also under the radar: “warning creep.” As atypical antipsychotics have gone into wide use in the population, more risks have surfaced. Labels now warn against death-associated risks in the elderly, children and people with depression but you have to really read the fine print. (Atypical antipsychotics are so dangerous in the elderly with dementia, at least 15,000 die in nursing homes from them each year, charged FDA drug reviewer David Graham in congressional testimony.) The Seroquel label now warns against cardiovascular risks, which the FDA denied until the drug was almost off patent.

Dosing Children

Perhaps no drugs but ADHD medications have been so widely used and often abused in children as atypical antipsychotics. Atypical antipsychotics are known to “improve” behavior in problem children across a broad range of diagnoses but at a huge price: A National Institute of Mental Health study of 119 children ages 8 to 19 found Risperdal and Zyprexa caused such obesity a safety panel ordered the children off the drugs.

In only eight weeks, kids on Risperdal gained nine pounds and kids on Zyprexa gained 13 pounds. “Kids at school were making fun of me,” said one study participant who put on 35 pounds while taking Risperdal.

Just like the elderly in state care, poor children on Medicaid are tempting targets for Big Pharma and sleazy operators because they do not make their own medication decisions. In 2008, the state ofTexas charged Johnson & Johnson subsidiary Janssen with defrauding the state of millions with “a sophisticated and fraudulent marketing scheme,” to “secure a spot for the drug, Risperdal, on the state’s Medicaid preferred drug list and on controversial medical protocols that determine which drugs are given to adults and children in state custody.”

Many other states have brought legal action against Big Pharma including compelling drug makers to pay for the extreme side effects that develop with the drugs: massive weight gain, blood sugar changes leading to diabetes and cholesterol problems.

Add-On Conditions

It’s called polypharmacy and it is increasingly popular: Prescribing several drugs, often as a cocktail, that are supposed to do more than the drugs do alone. Big Pharma likes polypharmacy for two obvious reasons: drug sales are tripled or quadrupled—and it’s not possible to know if the drugs are working. The problems with polypharmacy parallel its “benefits.” The person can’t know which, if any, of the drugs are working so they take them all. By the time someone is on four or more psychiatric drugs, there is a good chance they are on a government program and we are paying. There is also a good chance the person is on the drugs for life, because withdrawal reactions make them think there really is something wrong with them and it is hard to quit the drugs.

Into this lucrative merchandising model came the idea of “add-on” medications and “treatment-resistant depression.” When someone’s antidepressant didn’t work, Pharma marketers began floating the idea that it wasn’t that the drugs didn’t work; it wasn’t that the person wasn’t depressed to begin with but had real life, job and family problems—it was “treatment-resistant depression.” The person needed to add a second or third drug to their antidepressant, such as Seroquel or Abilify. Ka-ching.

Lawsuits Don’t Stop Unethical Marketing

Just as Big Pharma has camped out in Medicare and Medicaid, living on our tax dollars while fleeing to England so it doesn’t have to pay taxes, Pharma has also camped out in the Department of Defense and Veterans Affairs. Arguably, no drugs have been as good for Big Pharma as atypical antipsychotics within the military. In 2009, the Pentagon spent $8.6 million on Seroquel and VA spent $125.4 million—almost $30 million more than is spent on a F/A-18 Hornet.

Risperdal was even bigger in the military. Over a period of nine years, VA spent $717 million on its generic, risperidone, to treat PTSD in troops in Afghanistan and Iraq. Yet not only was risperidone not approved for PTSD, it didn’t even work. A 2011 study in the Journal of the American Medical Association found the drug worked no better than placebo and the money was totally wasted.

In the last few years, the makers of Risperdal, Seroquel and Zyprexa have all settled suits claiming illegal or fraudulent marketing. A year ago, Johnson & Johnson admitted mismarketing Risperdal in a $2.2 billion settlement. But the penalty is nothing compared with the $24.2 billion it made from selling Risperdal between 2003 to 2010 and shareholders didn’t blink. The truth is, there is too much money in hawking atypical antipsychotics to the general population for Pharma to quit.

This story originally appeared at AlterNet.

Read more here:http://www.rawstory.com/rs/2014/11/the-most-popular-drug-in-america-is-an-antipsychotic-and-no-one-really-knows-how-it-works/

Posted in Psychiatric drugs problems | Tagged , , | Leave a comment

Mother Charged With Murdering Daughter, 8, Asks Court for Psychiatrist

lisabatsone

Mother Charged With Murdering Daughter, 8, Asks Court for Psychiatrist

By Ann Blake-Tracy on December 12, 2014

lisa batsone

Lisa and Teagan Batstone

Lisa Batstone has been charged with murder after police found the body of her daughter in her trunk in British Columbia, CA when they came to assist her in pulling her car out of a ditch. The picture above was taken just four days before the murder. In court Lisa Batstone asked to see a psychiatrist.

In the very beginning of gathering these antidepressant cases I searched for the cases of mother’s killing their children – something that really stood out, something so rare that society had really hardly ever seen before and all of them were taking antidepressants. Of course when a drug can cause you to act out your worst nightmare in a dissociated state it seemed the best of moms were taking the lives of their children while under the influence of an antidepressant. Now, 25 years later, they seem to be a daily occurrence!

In 1999 I did the Leeza Gibbons Show on mothers on antidepressants killing their children. Robert Kirkwood came with me to talk about the nightmare he had just gone through when his wife, on Effexor, shot his two small children and herself. And a nurse, Christina Riggs (Amitriptyline), who had killed her two small children and almost succeeded in killing herself in a murder/suicide appeared via satellite from a prison in Arkansas. To add to her family’s nightmare the state of Arkansas, just short of one year later after she refused any appeals in her case, finished her unfinished suicide when they put her to death using the same drug she had tried to kill herself with the first time!

Within days after that show a nurse on Prozac killed her child less than an hour from that studio. She was one of three nurses to go to court within the same month oeriod after killing their children while under the influence of these deadly drugs. Her name was Cora Caro (Prozac). Her husband was a doctor. The other two were Marilyn Lemak (Zoloft), whose husband was also a doctor and the third nurse was Andrea Yates (Effexor and Remeron) who most people never heard that she was a nurse when her case shocked the world after she drowned her five small children in Houston, TX.

I still remember the long conversation I had with Andrea’s husband, Rusty, as I was driving through Kansas one day traveling to yet another case while explaining to him the REM Sleep Disorder where you act out your nightmares in a sleep state. After my explanation he said, “Without a doubt this was clearly the worst nightmare she could have ever had! She was totally devoted to the children!” She had even quit working to be home with them. In order to spend more time with them she homeschooled them. She knew she had started having children a little later in life than she had planned with her carreer and wanted to take advantage of being with them as much as possible. They were her world!

Once again I ask how many children must die before the world wakes up from this antidepressant-induced nightmare?!

ORIGINAL ARTICLE WITH DETAILS AND MANY PICTURES: http://www.dailymail.co.uk/news/article-2870885/Mother-charged-murder-eight-year-old-daughter-dead-trunk-car.html

Posted in Psychiatric drugs problems | Tagged , , , | Leave a comment

39-year-old woman who hanged herself after being assessed as a low suicide risk

blogger-image-313918022The Gloucestershire Review
Thursday, 23 October 2014

THE DISTRAUGHT family of a 39-year-old woman who hanged herself after being assessed as a low suicide risk have lashed out at the mental health treatment the mum-of-two received.

After an inquest into the death of Victoria Phelps of Wilton Road, Gloucester on August 6th, 2012, the mother of the deceased, Gayle Tucker said: “After one of her suicide attempts I begged that my daughter be sectioned so that she could be looked after properly.

“To say someone is at a low risk of suicide when she has made previous attempts is just not on. My daughter has been let down.”
Victoria’s brother Brett Phelps added: “My sister only started having suicide thoughts and making attempts when she was prescribed Fluoxetine. I’ve been doing some research into the drug and reckon that it was a death sentence for my sister.”

Senior Coroner for Gloucestershire Katy Skerrett said: “It is quite clear that from 1992 this lady suffered on-off with anxiety. She was a working lady with two sons and had been taking anti-depressants since 2000. “In April 2012 things came to a head due to a relationship breakdown and this triggered events in a bad way.”

Victoria took a drug overdose and was admitted to Gloucestershire Royal Hospital. She then waded into a canal and spoke to friends about ending her life, the inquest at Barnwood was told. Police Constable Karen Raistrick told the inquest: “I attended her home on a previous occasion when she tried to hang herself in the garage and I was on duty when I was again called to the house on August 6th that same year, but this time we found her dead.”

Victoria’s son had handed police a key to the garage and was just prevented in time by a friend from walking in and seeing his mother hanging by a dressing gown cord. Despite the previous history of anxiety and depression and suicide attempts, which included superficially cutting her wrist, mental health liaison nurse Julie Nicholson assessed her as being at low risk of self-harm “but this increased when alcohol was consumed.”

In a written statement to the inquest the nurse said that the family was asked to look after her medication “to reduce the risk of overdose.” “The patient did not want to die but told me that she would sometimes drift into a tunnel,” said the nurse. “She seemed flat and worried.”

Ms Skerrett reiterated the deceased’s recent mental health history: depression after an aunt died in 2005, anxiety in 2007 and 2008, panic attacks in 2009 and 2011, overdose and hospital admission in 2012, insomnia after relationship breakdown the same year, depressed and suicidal thoughts in July 2012.

She was referred to psychiatrist Prakash Muthu for a crisis assessment in July 2012 and he gave evidence at the inquest yesterday. “She told me about the overdose and the episode wading into the canal and also the cut wrists but she clearly regretted her actions, felt scared of what she had done and wanted help,” said the psychiatrist. “But she told me that she had no more suicidal thoughts and I assessed her as being of low risk of suicide. She maintained good eye contact during my assessment and seemed to be looking to the future.”

Dr Muthu said that he recommended a change in medication and told her that, as part of her risk management, she should contact The Samaritans. But the psychiatrist denied that there was an increased risk of suicide associated with Fluoxetine.

Ms Skerrett concluded that she could not be sure that Victoria intended to take her own life and there was reasonable doubt. “This may have been a cry for help and I will give a narrative conclusion,” she said. After retiring for ten minutes the coroner returned to the courtroom and delivered her narrative conclusion: “This 39-year-old lady was suffering from depression and anxiety, triggered by a relationship breakdown in March 2012. “She made a few suicidal attempts in the weeks preceding her death. However it is unclear whether she had formed a clear intention to die.”

Posted in Psychiatric drugs problems | Tagged , , | Leave a comment

‘I ask members of Congress to look those Newtown families in the eye’

Obama_Health_Care_Speech_to_Joint_Session_of_CongressWashington (CNN) — Tim Murphy was fascinated with trains at the age of 9. Every morning and evening, he went outside to watch an iron horse roar by on the railroad line that cut through Northfield, Ohio.

He placed pennies on the tracks. He waved at the engineer and watched the caboose disappear into the distance.

But one time, the train didn’t come. A patient from the nearby state psychiatric hospital had escaped and laid down on the tracks.

Murphy didn’t see the body, but news of the suicide hit hard.

He calls it his “first encounter” with mental illness.

“It was frightening to me, and I didn’t quite know how to comprehend this. But I remember being very shook up for a number of days.”

Now Murphy is a psychologist — the only one serving in Congress. And as the nation marks the second anniversary of the school massacre in Newtown, Connecticut, the representative from Pennsylvania is shook up.

The mantle he accepted and embraced in the aftermath of Newtown haunts him: to fundamentally change America’s mental health system.

“It’s two years and nothing’s happened. Period,” says Neil Heslin, whose 6-year-old boy, Jesse, was killed that day. “It is what it is.”

Murphy met with Newtown families whose children were killed in the massacre and pledged to dedicate his career to fixing a broken system. As a reminder, he keeps photographs of the children on a table in his office.

He traversed the nation, holding dozens of public forums on mental illness and meeting with hundreds of families affected by a system that too often fails their mentally ill children. The Republican congressman held multiple hearings looking into the state of the nation’s mental health care system.

Even with his years of training, Murphy still gets taken aback when he hears stories from families. He marvels at the love of traumatized parents and ponders tough questions: Why has mental health care abandoned those it is meant to help the most?

What emerged from his work was legislation that seeks to make the most sweeping change in the system in more than two decades.

But it’s almost as though Murphy’s Law got in the way of Murphy’s law: Everything that could go wrong did.

A Democratic bill introduced this spring scuttled bipartisanship and undercut his hard work. House leaders raised budgetary concerns. International crises in Iraq and Syria diverted attention over the summer. And a fickle public moved on.

Two years after Newtown, the nearly 14 million Americans with serious mental illness must navigate the same patchwork system that failed the nation on December 14, 2012.

Says Murphy: “I ask members of Congress to look those Newtown families in the eye.”
Police evacuate children from Sandy Hook Elementary School in Newton in 2012.
Shannon Hicks/The Newtown Bee

A message of hope

From the beginning, Murphy was emphatic about what drove Adam Lanza to kill 26 people, including 20 children inside Sandy Hook Elementary School. In a closed-door meeting — what he called Psychology 101 — with House Republicans two years ago, he told fellow lawmakers to stop turning a blind eye to mental illness.
Report: Lanza preoccupied with violence

“I see it as the center of the issue,” he said. “Get mental illness out of the shadows.”
Photos: Worst mass shootings in U.S. Photos: Worst mass shootings in U.S.

On an appearance on CBS’s “Face The Nation,” the congressman blasted those who blamed violent video games as the genesis for the shooting spree. “We’re chasing the wrong rabbit down the wrong hole,” Murphy said. “We need to be addressing mental illness, and we’re not.”
Reaction to Newtown school killings Reaction to Newtown school killings

If 20-year-old Lanza and 26-year-old Jared Loughner had been forced into treatment, Murphy says, the tragedies in Newtown and Tucson could have been averted.

Loughner pleaded guilty in the January 8, 2011, attack that killed six and wounded Arizona Rep. Gabby Giffords and 12 others — and was diagnosed paranoid schizophrenic only after he went to prison.

Patient advocacy groups always say, ” ‘Well, you couldn’t have predicted that.’ Yes, you can,” Murphy says, his voice rising. “In each of those cases, the family knew that their son had a serious mental illness, and they couldn’t get them help.”

Laws prevent parents and caregivers from being involved in children’s health care decisions once they turn 18 — even for the most seriously mentally ill who have cycled in and out of psychiatric care for years.

His bill — introduced this time last year — would allow more parental involvement in a young adult’s care, create a new assistant secretary for mental health and make it easier to commit people to court-ordered treatment against their will.

The issue of forced treatment is highly contentious among civil libertarians and patient rights advocates. It ignited a civil war inside the mental health community. The key argument: Should a seriously mentally ill patient be medicated over their objections as a last resort, or does that approach violate their civil liberties?

Murphy’s bill would also gut more than $400 million from the Substance Abuse and Mental Health Services Administration (SAMHSA) and move the money to the National Institutes of Mental Health for effective programs with evidence-based research to get people better. As Murphy puts it, treatment should be “led by a doctor, not a lawyer.”

“We need to bring mental health treatment into the 21st century,” he says.

Patient rights groups wholeheartedly reject his approach. They see his bill as a two-pronged attack: They lose funding, and the mentally ill lose rights.

Murphy’s supporters consider him a savior of the mentally ill. His critics call him a bully trampling individuals’ rights.

Though his bill will die in this lame-duck session, he will reintroduce the legislation, possibly with some tweaks, next year to a GOP-controlled Congress. He has 115 co-sponsors, including nearly 40 Democrats onboard.

To the families he has met over the past two years, he has a message of hope: “Their voice is being heard, and it will not be simply dismissed.”

“Our bill really pushes for solutions to help address the unique needs of not only those with serious mental illness, but families and communities and caregivers.”
Congress has done little to answer calls for gun control and mental health reform since Newtown.
Jessica Hill/AP

A lifelong commitment to the mentally ill

Murphy grew up one of 11 children, the fourth from the oldest in his family. His father was a podiatrist, and his mother was a nurse. His first paying job, at 10, was cleaning horse stables at a nearby farm.

“We mucked up the stalls for 50 cents, and I could ride horses,” he says. “I like to say that sometimes the difference between that and Congress is: I don’t get to ride horses.”

Living in a large household helped shape his views. Siblings, cousins, aunts and uncles crammed the home for family events. There were things every family member knew, Murphy says, but no one ever talked about.

“And those things take a toll on a family,” he says. “And maybe it was the sum of those many experiences that certainly drove me to, instead of being afraid of mental illness, to be compassionate and driven towards saying, ‘I’m going to walk into this and dedicate my life to changing things so that other people don’t have to feel the pain.’ ”

Pressed about his devotion to the mentally ill, Murphy, 62, says he watched “things erode and decay” during his formative years with friends and family. But he stops there, saying only that there was a great deal of sadness involved.

“Some day I’ll disclose,” Murphy says, “but I’m not comfortable with that yet.”

His interest in psychology grew as he went off to college. He earned his bachelor degree from Wheeling Jesuit University in West Virginia in 1970, before seeking a master’s in clinical psychology from Cleveland State University and working at a community mental health center.

“I found the field of psychology fascinating,” he says. “The more I got into it, the more I felt this is where I could make some difference.”

He earned his PhD in psychology from the University of Pittsburgh and worked in various Pennsylvania hospitals. He became an assistant professor of psychology at the University of Pittsburgh and was known as “Dr. Tim” from appearances on local television.

He opened his private practice around 1987.

He came along at a time when the main psychiatric hospital in Pennsylvania, even in the early 1980s, still used archaic treatment practices, such as dunking patients suffering from depression into ice water, thinking it would snap them out of it. “The asylums of yesteryear needed to be torn down,” he says.

As a young psychologist, he heard horrific stories of sexual abuse of children and “physical beatings that were awful.” He counseled those children and fought for their well-being.

More recently, he joined the Naval Reserve in 2009, and every month spends two days at Walter Reed hospital counseling war veterans suffering from traumatic brain injuries and post-traumatic stress disorder. “I thought if I’m going to be voting to send them over to war, then I have a responsibility to help them when they return,” Murphy says.

When he informed a wife of the extent of her husband’s war wounds, she left him; the spouse of another had the opposite reaction: “If it takes me 50 years, I’ll teach him to laugh and love again.”

In the stories and struggles of his patients, Murphy finds resolve. “You develop a lot of what they call ‘compassion fatigue,’ ” he says. “But then, I’d say, ‘That’s nothing compared to what people face.’ And it just gives you strength.”

Dennis Roddy, a long-time journalist in Pittsburgh who went on to become an aide to Pennsylvania Gov. Tom Corbett, says it was considered an oddity when Murphy became a state senator in 1996. The stigma of mental illness was so prevalent, Roddy says, that some constituents had a hard time with the thought of a psychologist in office and wondered: “Should we feel comfortable about it?”

“He was at the forefront of the politicians who recognized the dilemma” of mental illness, Roddy adds. “When he got into Congress, he waited and worked his way until he was in a position to do something about it.”

Politics PA, a buzzy blog tracking the state’s political scene from Erie to Philadelphia, once dubbed Murphy one of the smartest lawmakers in the state.

“He has the capacity to pay attention and the talent to listen,” Roddy says. “This psychologist doesn’t look at the clock and say, ‘I see our time is up.’ ”
Last year Murphy introduced the most sweeping mental health bill in more than two decades.
Pablo Martinez Monsivais/AP

Opponent: ‘Back to the Dark Ages’

Curt Decker, executive director of the National Disability Rights Network, doesn’t buy it. He believes Murphy used his position as a psychologist to curry favor among GOP leadership, “bootstrapped onto Newtown” and was sold a bill of goods by those who believe medication over objection is the answer to treating the seriously mentally ill.

“I would say he puts out there that he cares about this population, and he really doesn’t,” Decker says. “In the meantime, it adds to the stigma.”

The Murphy bill, he says, focuses on a “coercive lock-them-up and throw-away-the-key kind of approach and ignores the whole movement that’s been going on in the mental health community for the last couple decades” — one based on recovery and support systems within communities.

Decker agrees with Murphy that the mental health system must be revamped to repair “this really dangerous patchwork of services.” He just doesn’t like Murphy’s approach.

To be clear, Decker has a beef with Murphy. He says his Disability Rights Network would see its federal funding shrink from $38 million a year to $5 million under Murphy’s plan. He says Murphy puts on this public persona that he’s willing to work with his opponents, but then “he brings them in and yells at them.”
Photos: Newtown school shooting Photos: Newtown school shooting

His group represents thousands of mentally ill patients around the country to make sure the abuses of the past never return.
Parents of mentally ill children struggle for care

Nancy Jensen testified before one of Murphy’s congressional hearings. A victim of sexual and physical abuse at a Kansas group home, Jensen urged lawmakers not to support the bill because of massive cuts to patient advocacy groups, like the ones that saved her from further horrors.
‘Crystal clear something was wrong’

“What he’s trying to do is kind of scary,” she says. “If he takes away Protection and Advocacy for Individuals with Mental Illness, then we do go back to the Dark Ages where we can be involuntarily committed someplace and abused and neglected.”

On that point, Murphy pushes back. And hard.

Spinmasters, he says, have distorted his bill to scare away support. He is all for current comprehensive approaches — peer support, medication, psychotherapy, group therapy, safe housing. Yet he ardently rejects the status quo — $130 billion in federal funds, with what he says are millions upon millions being wasted on “feel-good” programs that don’t work.

If patient advocacy programs were so effective, he says, then why over the past 20 years “have we seen an increase in incarcerations, suicides, substance abuse, suicide attempts, suicidal thoughts, homelessness, disability and unemployment among the mentally ill.”

“On every metric,” Murphy says, “this country is failing.”

His opponents, he says, are perfectly fine with the mentally ill going untreated: “These groups push for a right to be sick, a right to be homeless, a right to be in jail, a right to be unemployed.”

“If people want to defend that, then put that in front of the American public, because the American public does not agree with them. People have a right to get better.”

There is no doubt that treatment works, Murphy says, even for the most seriously mentally ill. He knows that from counseling hundreds of patients over the years and from court-ordered programs that help the seriously mentally ill, but only after they have committed a major crime.

“Why not fight for what is right, what is appropriate, what is necessary?”

And so Murphy persists.

Despite critics. Despite a stalled Congress. Despite waning public interest.
Rep. Ron Barber of Arizona has proposed a competing mental health bill.
Tom Williams/CQ Roll Call/Getty Images

Murphy: ‘In this together’

At a hotel ballroom in the nation’s capital, Murphy stands in front of more than 1,000 people for the keynote address of the annual conference of the National Alliance on Mental Illness, the largest nonprofit mental health advocacy group.

It’s early September, and Murphy hopes to ignite these advocates to get their lawmakers to lend their support in advance of the midterm elections.

Moments earlier, Democratic Rep. Ron Barber of Arizona appeared via video to promote his own mental health bill — one that was introduced this spring and has garnered little bipartisan support. As Murphy prepares to speak, murmurs bounce around the room:

If there are two bills, why can’t they just work together and hammer out an agreement?

Barber was a key staffer for Giffords and was among the 13 wounded in the attack that nearly killed her. He knows first-hand the horrific effects of untreated mental illness.

Barber assumed Giffords’ seat in June 2012. His bill avoids the controversial treatment provisions of Murphy’s, instead focusing on creating a White House Office of Mental Health Policy, continuing to support the funding of SAMHSA and other initiatives.

“It is imperative that we find a way to establish common ground on provisions in each bill that we both support and move forward with a bipartisan bill that can pass the House and garner bipartisan support in the Senate,” Barber says. (Barber is currently steeped in a recount in Arizona, and his staff would not make him available for an interview for this story but provided a written statement echoing his NAMI comments.)

But Murphy won’t budge. He believes his bill is too critical in meeting the needs of the seriously mentally ill: “Why would I want to compromise when you hear these stories over and over?”

Murphy looks out over the crowd. He’s met many of them over the past two years as he’s traveled the country or hosted congressional hearings. He immediately sets the tone.

“I’m not interested in just passing a bill. I’m interested in making a fundamental change to America’s abuse of the mentally ill,” he says to raucous applause.

He speaks for 55 minutes, stepping the audience through the changes he has proposed and why he believes so adamantly about the most drastic portions of his bill. His speech is interrupted by applause 30 times.

He urges the crowd to tell their representatives to support the bill. “You are an army of soldiers with the biggest hearts and greatest love that is out there,” Murphy says. “There’ll be people out there who fire upon you slings and arrows of lies and stigmas and deceit and mistrust.”

When those people attack, Murphy says to stand strong. “We are in this together.”
A makeshift memorial stands outside a home in Newtown on the one-year anniversary of the shootings.
Robert F. Bukaty/AP

Sorrow, stigma and heartache

A woman trembles: “My daughter Sarah died by suicide on July 16.”

Says one man: “My brother got better treatment in 1957 than he would today.”

On and on, the stories keep coming from people gathered in the Rayburn Office Building to talk with Murphy. Sons, daughters, brothers, sisters, husbands, wives. They’re locked away in prisons; they’re homeless; they’re untreated; they’re dead.

These families hail from California, Kentucky, New York, Oklahoma, Ohio and Pennsylvania. It doesn’t matter where they’re from: their stories are the same — a mental health system laden with hurdles and bureaucracy that makes it difficult to get proper care.

Murphy agreed to meet with families in advance of his keynote speech at the NAMI conference. It was supposed to be a small gathering, but word spread among families, and the numbers swelled.

“No one came in here saying what party they’re in,” Murphy tells the group. “I know that mental illness doesn’t discriminate by party, by race, by age, by income.”

The congressman listens to their stories and engages with each on a personal level. “I want to hear from you,” he tells them. Dressed in a navy suit, he stands in front and points around the room to individuals who recite their travails.

“Every time you think your heart can’t take any more,” Murphy says later, “you hear more.”

Rich Mandich and his wife, Joyce, sit in the front row. Like a shaken Coke bottle, Rich is about to burst, his emotions pent up for three years.

“I want to tell you about my son, Steven,” he tells Murphy.

His son was 28 and suffered from schizophrenia. Police in Bedford, Ohio, knew him well. They’d responded to the home dozens of times during his meltdowns over the years.

Shortly before 6 p.m. on November 26, 2011, Steven called 911 to say his father had his medications. “They laughed at him,” Mandich says. “They thought it was funny.”

His wife moans, her body shakes.

Police came to the home. Mandich says he tried to intervene, but was Tasered and dragged out of the home by officers. His son had a knife in his hands and was Tasered multiple times, before being shot to death in his bedroom. Police said he lunged at them with a knife.

The family eventually filed suit against those involved. It was settled out of court for an undisclosed amount.

Mandich had always been his son’s protector, but “that day, I couldn’t save him because they got in the way.” He breaks down, years of bottled-up pain welling over.

Murphy takes off his glasses and wipes his eyes. “He had rights and you had rights,” Murphy tells the father. “He had a right to go and live a full life.”

“He was a valuable person to us,” Mandich says. “This kid had a kind heart.”

The two agree that Steven Mandich deserved better treatment than being gunned down in his room. It is an important acknowledgment for a family still grieving — to hear someone in power say that their son mattered.

When the session ends, Murphy strolls outside around the nation’s Capitol, unable to shake the power of the Mandiches’ story.

“They lost their loved one long ago,” he says, “but they’ve never lost their hope that something can change.”

The congressman is energized. In his view, the very least he can do is maintain that hope — that changing the system is worth the fight

Posted in children and teens, mental health and well being | Tagged , | Leave a comment

Psychiatrists’ Prescriptions for First-time Psychosis Often Don’t Follow Guidelines

Psychiatrists-become-mentally-ill.gifJustice-qui-sont-les-experts-psychiatres_imagePanoramique500_220Psychiatrists’ Prescriptions for First-time Psychosis Often Don’t Follow Guidelines

December 12, 2014

“Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment,” states a National Institute of Mental Health press release about a new NIMH study published in the American Journal of Psychiatry. The study found that about 40% of patients who’d been diagnosed with having psychotic experiences for the first time in their lives were being too heavily medicated right away.

The study is part of the Recovery After an Initial Schizophrenia Episode (RAISE) project, “which was developed by NIMH to examine first-episode psychosis before and after specialized treatment was offered in community settings in the United States,” states the press release. “RAISE seeks to change the path and prognosis of schizophrenia through coordinated and intensive treatment in the earliest stages of illness… Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.”

The researchers found that, out of 159 people,

8.8 percent were prescribed higher-than-recommended doses of antipsychotics;
23.3 percent were prescribed more than one antipsychotic;
36.5 percent were prescribed an antipsychotic and an antidepressant without a clear need for the antidepressant;
10.1 percent were prescribed psychotropic medications without an antipsychotic medication,
and 1.2 percent were prescribed stimulants.
In addition, 32.1 percent were prescribed olanzapine, a medication not recommended for first-episode patients.
Some of the 159 people fell into multiple categories.

“Despite some regional variations in prescription practices, no region consistently had different practices from the others,” wrote the authors of the study. “Diagnosis had limited and inconsistent effects.”

Medications for patients with first episode psychosis may not meet guidelines (National Institutes of Health Press Release, December 4, 2014)

(Abstract) Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data From the National RAISE-ETP Study (Robinson, Delbert G. et al. American Journal of Psychiatry. Published online ahead of print December 4, 2014.)
This entry was posted in Featured News, In the News, Psychiatric Drugs, Schizophrenia and Psychosis, Schizophrenia and Psychosis by Rob Wipond. Bookmark the permalink.

Posted in Psychiatric drugs problems | Tagged , , , | Leave a comment

ANTIDEPRESSANTS AND WEIGHT GAIN

obese-woman-very-fatobese_532_1505287a

Experts say that for up to 25% of people, most antidepressant medications — including the popular SSRI (selective serotonin reuptake inhibitor) drugs like Lexapro, Paxil, Prozac, and Zoloft — can cause a weight gain of 10 pounds or more.

“This is a phenomenon that I first noticed years ago when Prozac first came on the market. It didn’t initially show up in the clinical trials because most of them were eight to 12 weeks in length, and the weight gain generally occurs with longer use. But it’s definitely one of the side effects of this and other antidepressant medications,” says Norman Sussman, MD, a psychiatrist and associate dean for postgraduate medical programs at the NYU School of Medicine.

A review published in 2003 in the Cleveland Clinic Journal of Medicine stated that while weight gain is a possible side effect with SSRI antidepressant drugs, it may be more likely to occur after six months or more of use.

But SSRIs aren’t the only class of antidepressants that may have weight gain as a side effect. Other antidepressant medications, including tricylics (like Elavil and Tofranil) and MAO inhibitors (drugs like Parnate and Nardil), may also cause patients to gain weight with both long-term and short-term use.

“This is clearly a problem for the majority of drugs used to treat depression, and while it doesn’t occur with every drug or for every person, when it does happen, it can be a significant problem that we shouldn’t just ignore,” says Jack E. Fincham, PhD, RPh, professor of pharmacy practice at the School of Pharmacy at the University of Missouri at Kansas City, and author of The Everyday Guide to Managing Your Medicines.

Although there are a number of theories as to why antidepressants lead to weight gain, Sussman believes that both appetite and metabolism may be affected.

Posted in Psychiatric drugs problems | Tagged , , , | Leave a comment

SAFETY UPDATE CLINICIENNE (CHAMPIX, CHANTIX) AND SERIOUS PHYSCIATRIC ADVERSE EFFECTS

Doctor and Woman Examining PillsSAFETY UPDATE CLINICIENNE (CHAMPIX, CHANTIX) AND SERIOUS PHYSCIATRIC ADVERSE EFFECTS

Editor’s Note: The basis for this article is US Food and Drug Administration (US FDA) Briefing Documents. These documents are detailed analyses prepared for and made public prior to a joint meeting of the Psychopharmacologic Drugs and Drug Safety and Risk Management Advisory Committees held October 16, 2014. This meeting was held to discuss severe psychiatric adverse from the smoking cessation drug varenicline (Champix, Chantix). [1] These documents may include unpublished analyses and clinical trials that contain important drug safety information for patients.

In April 2014, Pfizer, Inc. the manufacturer of varenicline submitted a request to the US FDA to change the professional product information written for doctors and pharmacists to say that varenicline does not cause serious psychiatric adverse effects. The request included removing the strongest type of warning the US FDA can require, a box warning from the drug’s professional information. These serious adverse reactions include depression, suicidal ideation, suicide attempt, and completed suicide.

The US FDA scientists and professional staff who reviewed Pfizer’s request found its quality to be poor and said the request, “… provided evidence of insufficient quality to either rule in or rule out an increased risk of suicide, non-fatal self-harm, or neuropsychiatric hospitalizations associated with varenicline use.”

The 18 members of the advisory committees agreed with the US FDA and soundly rejected Pfizer’s request with 11 voting to retain the current warnings; 6 voted to strengthen the warnings; and only 1 member agreed with Pfizer.

Varenicline was initially approved in in the US in May 2006 as an aid to smoking cessation. In May 2007, the European Medicines Agency (EMA- previously, EMEA) informed the FDA that they were investigating a signal of suicidality-related adverse events. It is estimated that varenicline is sold in 90 countries worldwide.

In early 2008, the US FDA determined that varenicline was associated with serious psychiatric adverse events including suicidal ideation, suicidal behavior, changes in behavior, agitation, depressed mood, and worsening of preexisting psychiatric illness.

By May 2008, the US FDA required that varenicline be dispensed with safety information written specifically for patients called a Medication Guide. A Medication Guide can be required for drugs that present significant public health concerns when patients need useful accurate information to decide to start or continuing taking a particular drug.

Two months later, in July 2009, the US FDA required the strongest type of warning in the information written for doctors and pharmacists, a Box Warning. Additionally, the Warnings section of the professional information was updated to include additional varenicline associated serious psychiatric adverse events including hostility, mania, psychosis, hallucinations, and paranoia.

Pfizer is conducting a Phase IV trial, a type of clinical trial that provides the strongest type of evidence, to examine varenicline’s psychiatric safety. The target completion date is August 2016. The best safety advice for patients is to Avoid Using varenicline until the results of this trial are known. The safety warnings about varenicline had a significant impact on sales of the drug in the US. The number of patients receiving a prescription for varenicline decreased from approximately 3.9 million in 2007 to approximately 1.2 million patients in 2013.

Below is the current version of varenicline’s Box Warning.
WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS

Serious neuropsychiatric events including, but not limited to, depression, suicidal ideation, suicide attempt, and completed suicide have been reported in patients taking CHANTIX. Some reported cases may have been complicated by the symptoms of nicotine withdrawal in patients who stopped smoking. Depressed mood may be a symptom of nicotine withdrawal. Depression, rarely including suicidal ideation, has been reported in smokers undergoing a smoking cessation attempt without medication. However, some of these symptoms have occurred in patients taking CHANTIX who continued to smoke.

All patients being treated with CHANTIX should be observed for neuropsychiatric symptoms including changes in behavior, hostility, agitation, depressed mood, and suicide-related events, including ideation, behavior, and attempted suicide. These symptoms, as well as worsening of pre-existing psychiatric illness and completed suicide, have been reported in some patients attempting to quit smoking while taking CHANTIX in the postmarketing experience. When symptoms were reported, most were during CHANTIX treatment, but some were following discontinuation of CHANTIX therapy.

These events have occurred in patients with and without pre-existing psychiatric disease. Patients with serious psychiatric illness such as schizophrenia, bipolar disorder, and major depressive disorder did not participate in the premarketing studies of CHANTIX.

Advise patients and caregivers that the patient should stop taking CHANTIX and contact a healthcare provider immediately if agitation, hostility, depressed mood, or changes in behavior or thinking that are not typical for the patient are observed, or if the patient develops suicidal ideation or suicidal behavior. In many postmarketing cases, resolution of symptoms after discontinuation of CHANTIX was reported, although in some cases the symptoms persisted; therefore, ongoing monitoring and supportive care should be provided until symptoms resolve.

The risks of CHANTIX should be weighed against the benefits of its use. CHANTIX has been demonstrated to increase the likelihood of abstinence from smoking for as long as one year compared to treatment with placebo. The health benefits of quitting smoking are immediate and substantial.

Additional Warnings and Precautions When Taking Varenicline Please Note: The following information is derived in part from the current US FDA approved professional product labeling and Medication Guide for varenicline. The complete professional information and Medication Guide for the drug are available on the DailyMed Web site at http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0ff4f27-5185-4881-a749-c6b7a0ca5696.

Seizures. Some people have had seizures during treatment with varenicline. In most cases, the seizures have happened during the first month of treatment. If you have a seizure during treatment with varenicline, stop taking varenicline and contact your healthcare provider right away.

Use caution when driving or operating machinery until you know how varenicline affects you. Varenicline may make you feel sleepy, dizzy, or have trouble concentrating, making it hard to drive or perform other activities safely.

Currently, the US Federal Aviation Administration has banned the use of varenicline by pilots and air traffic controllers.[2]

Decrease the amount of alcoholic beverages that you drink during treatment with varenicline until you know if varenicline affects your ability to tolerate alcohol. Some people have experienced the following when drinking alcohol during treatment with varenicline:

increased drunkenness (intoxication)

unusual or sometimes aggressive behavior

no memory of things that have happened

New or worse heart or blood vessel (cardiovascular) problems, mostly in people, who already have cardiovascular problems. Tell your doctor if you have any changes in symptoms during treatment with varenicline. Get emergency medical help right away if you have any of the following symptoms of a heart attack, including:

chest discomfort (uncomfortable pressure, squeezing, fullness or pain) that lasts more than a few minutes, or that goes away and comes back pain or discomfort in one or both arms, back, neck, jaw or stomach

shortness of breath, sweating, nausea, vomiting, or feeling lightheaded associated with chest discomfort

Allergic reactions can happen with varenicline. Some of these allergic reactions can be life threatening.

Serious skin reactions, including rash, swelling, redness, and peeling of the skin. Some of these skin reactions can become life threatening. Stop taking varenicline and get medical help right away if you have any of the following symptoms:

swelling of the face, mouth (tongue, lips, and gums), throat or neck

trouble breathing

rash with peeling skin

blisters in your mouth

What You Should Do You should Avoid Using varenicline until at least August 2016 when the results of the Pfizer safety study are known. At this time the safest option as an aid for smoking cessation appears to be nicotine in its various forms such as patches, gum, or lozenges. References 1. US Food and Drug Administration. Briefing Information for the Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management, Advisory Committee (DSaRM), October 16, 2014. At http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418705.pdf. Accessed October 19, 2014. 2. US Federal Aviation Administration. Pharmaceuticals (Therapeutic Medications) Do Not Issue – Do Not Fly, revised August 6, 2014. Athttps://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/pharm/dni_dnf/. Accessed October 19, 2014.

Posted in Psychiatric drugs problems | Tagged , , | Leave a comment

Lives destroyed by happy pills

article-1290402-03CCFBA7000005DC-405_468x364Lives destroyed by happy pills: As our use of antidepressants DOUBLES in a decade, experts say thousands are being given dangerous drugs they don’t need

By Jerome Burne for MailOnline
Updated: 07:00 GMT, 29 June 2010

View comments

Clare Morgan was going through a rocky patch: her long-standing relationship had hit difficulties and she was struggling financially. But the self-described ‘optimist’ felt she was managing to cope.

Then the 35-year-old biologist started experiencing unusual symptoms. ‘Out of the blue, I felt really agitated – I couldn’t concentrate, I couldn’t sleep, and I felt very shaky,’ she recalls. ‘I’d been under some stress. But my symptoms seemed too odd for that to be the whole explanation.’

After about six weeks she went to see her doctor, who diagnosed depression and anxiety. ‘I asked him if he was sure, because there were other symptoms such as diarrhoea, weight-loss and vomiting. But he confirmed his diagnosis and prescribed an antidepressant.’
Increasing numbers of Britons are taking antidepressant drugs, with prescriptions doubling over the past ten years, according to a report this month

Increasing numbers of Britons are taking antidepressant drugs, with prescriptions doubling over the past ten years, according to a report this month

Unfortunately this only made her feel worse; she developed the shakes as well as suicidal thoughts. In an attempt to remedy this, her GP changed the medication three weeks later. But nothing changed.

And after mentioning her suicidal thoughts to her doctor, she was put under the supervision of a mental health team.

Six weeks later, Clare was put on yet another antidepressant, along with a tranquilliser and an anti-psychotic drug. She was now sleeping 14 hours a day; unable to work, she had to rely on her boyfriend for support.

‘I was zombified, but still felt the anxiety and the terror, and that didn’t seem right. However, my doctor simply increased my dose.’

After six miserable months, Clare’s doctor admitted the drug treatment wasn’t working and suggested electric shock treatment. ‘I said “no way” and decided to come off the antidepressants,’ she says. This proved ‘fantastically hard – worse, actually, than being on them’.

‘The only good part was a brilliant nurse, who took me seriously when I said I’d always felt that something physical had caused my symptoms and put me in touch with a sympathetic private doctor,’ she says.

A year-and-a-half after her symptoms began, Clare was diagnosed with an overactive thyroid and a problem with her adrenal glands. ‘That was why I had been so bizarrely agitated, had diarrhoea and had lost weight.’
Depression Check.jpg

Clare’s story is extreme, but it is far from unique. Increasing numbers of Britons are taking antidepressant drugs, with prescriptions doubling over the past ten years, according to a report this month. In 2000, there were 20 million prescriptions – this rose to 39 million last year.

While this rise is partly being blamed on the recession, experts are concerned that misdiagnosis is a major factor. Indeed, a study published recently in The Lancet found that the average GP will wrongly diagnose 16 out of every 100 patients they see with depression and anxiety.

As Dr Alex Mitchell, consultant psychiatrist at Leicester General Hospital, explains: ‘A busy GP sees about 100 patients a week. Out of those, 20 will be suffering from depression, but he will spot only ten of them and treat five, usually with drugs.’

Not only are the depressed missing out on treatment, 16 of those 100 patients will be told they are suffering from depression when they aren’t.

One of the reasons this happens is because the official test GPs use to check if you’re depressed involves two very basic questions: During the past month, have you been bothered by feeling down, depressed or hopeless?

During the past month, have you been bothered by having little interest or pleasure in doing things?

‘Ideally, GPs shouldn’t just rely on these two questions, although they are a NICE-approved way of diagnosing depression,’ says Dr Mitchell.

‘It’s not really GPs’ fault,’ he adds. ‘They haven’t got enough time to give longer questionnaires. We did find that serious cases were less likely to be missed than milder ones.’

But Dr Mitchell’s research shows that at least two patients a week will walk out from an average surgery with a prescription for a totally unnecessary and possibly damaging antidepressant. That adds up to hundreds of thousands of patients in the UK every year.

most commonly used drugs for depression are SSRIs, or selective serotonin reuptake inhibitors – they come with a range of nasty potential side-effects.

Those for Seroxat, for instance, include loss of appetite, severe mental/ mood changes, uncontrolled movements, irregular heartbeat and a raised risk of cataracts.

As well as side-effects from a drug you possibly shouldn’t even be taking, coming off such drugs can be extremely difficult, as Clare Morgan found.
‘The problem is that antidepressants have side-effects and can increase the risk of suicide when given to children or young adults,’ says Professor Kirsch

‘The problem is that antidepressants have side-effects and can increase the risk of suicide when given to children or young adults,’ says Professor Kirsch

‘The doctors said there were no withdrawal problems, but when I tried to stop taking them, the panic and horror became so great I wanted to kill myself. I even searched for details on the internet about hanging myself. I didn’t want to live like that.’

Then she came across a charity which specialised in withdrawal from prescription medication. The Liverpool-based Council for Information on Tranquillisers and Antidepressants is one of the few such centres in the UK.

‘We are seeing an increasing amount of people who have a serious problem coming off SSRI antidepressants,’ says Pam Armstrong, a nurse consultant and co-founder of the charity. ‘Doctors are happy to put people on them, but they haven’t a clue about getting them off.’

For the majority of people, misdiagnosis and withdrawal problems are not, however, an issue. For them, the real question is whether the drugs are actually effective. Many say antidepressants have really helped them.

But now, one dogged researcher has found the drugs are no better than a placebo – and that the drugs industry has tried to hide this.

Professor Irving Kirsch, a psychologist at Hull University, used the Freedom of Information Act in the U.S. to get access to all the data the pharmaceutical companies had submitted when their drugs were licensed.

As well as finding that the negative results were not published, when Professor Kirsch combined the results from the published and unpublished trials, all brands of SSRIs showed up as little better than a placebo.

Even worse, Kirsch says that both the drugs companies and the U.S. regulators knew this, but chose to keep it from doctors and their patients.

He quotes an internal Federal Drug Administration memo saying it was ‘of no practical value to patient or physician’ to reveal that SSRIs are no better than placebos.

But if people do get better on antidepressants, what’s the problem? ‘The problem is that antidepressants have side-effects and can increase the risk of suicide when given to children or young adults,’ replies Professor Kirsch.

Since 2004, NICE has recommended that patients with mild to moderate depression or anxiety should be offered a talking therapy

‘There are safer and more effective alternatives,’ he says, referring to talking therapies.

In fact, officially these are precisely the sort of treatment Clare Morgan and many others should be getting, instead of ‘harmful’ drugs. Since 2004, NICE has recommended that patients with mild to moderate depression or anxiety should be offered a talking therapy.

The one with the best evidence is called cognitive behaviour therapy (CBT), which concentrates on changing the thoughts that go with negative feelings.

The benefits are clear: those getting this treatment are less likely to relapse than those on antidepressant medication. In one study, the relapse rate was 5 per cent on therapy, 40 per cent on the drugs.

Even patients who feel they have benefited from antidepressants often appreciate help from a therapist as well, as Louise Luxton, a 36-year-old make-up artist living in London, discovered.

She’d suffered from anxiety and was put on Prozac, ­but ‘felt terrible’.

She says:­ ‘Seroxat worked better for a while. ­But years later when things got really bad, ­Seroxat didn’t help at all.’

What did help was medication in combination with a talking therapy.

‘The therapist taught me techniques to use when the anxiety gets too bad and he found the right drug for me. I wish I’d been able to see him a lot earlier.’

She’s now happily married and planning to have a baby.

But talking therapy is infamously hard to find. Nearly three-quarters of GPs say they hand out pills becasue therapy just isn’t available, a recent study by the Mental Health Foundation found.

Indeed, Louise had to pay for treatment privately. ‘If you don’t have that sort of money, your prospects can be pretty grim,’ she says.

Three years ago, the Government announced it was spending £173million on training an army of 3,600 extra therapists which could be rolled out across the country by 2011 to provide CBT to all those suffering from depression and anxiety.

Professor David Clark, who heads up the scheme, is optimistic about reaching this target: ‘By 2011, we are due to have all the therapists in place and we will have provided treatments to an extra 900,000 patients over the three years,’ he says.

So far, 115 out of 154 primary care trusts in England have agreed to set up a centre.

But as Good Health has discovered, the roll-out of the scheme nationally may be having the effect of actually reducing the number of therapists in some areas.

Mariam Kemple, of the mental health charity Mind, explains. ‘We’ve been getting reports that when the money to set up one of the new centres comes through, the primary care trust cancels contracts with existing therapists, saying the centre will be providing treatment for depression and anxiety in future.’

Similar reports have come in from the British Association for Counselling and Psychotherapy.

‘The whole point of the project to roll out new therapy centres was to make up for the serious shortage of talking treatments,’ says Paul Farmer, chief executive of Mind. ‘We would be extremely worried if some trusts are axing existing services and using the new one as a replacement.’

Professor Clark blames the way funding is going into the local trusts’ general pot – ‘some may have been deciding to save money on existing provision’.

Although the Government has just pledged to spend £70 million over the next year providing more therapists and centres, this is not going to be ring-fenced.

This provision matters, as Clare Morgan knows only too well.

‘If I’d been able to see a therapist initially, everything might have been different. Someone might have spotted that my symptoms weren’t necessarily depression,’ she says.

Now taking steroids for her condition, she is training to become a science teacher.

‘Lots of people say they benefit from antidepressants, but doctors need to be more responsive when patients say they are having a bad time with them. Increasing the dose is often not the answer.’

Visit backtolife.uk.com, mind.org.uk and bacp.co.uk for more information.
THE FIVE TYPES OF DEPRESSION

By top psychologist Dr Cecilia d’Felice

REACTIVE

SYMPTOMS: Inability to face the day and cope with routine situations. You feel tearful, overwhelmed, angry and lacking in any options to make things better. For example, you’re convinced you’ll never get another job and that your life is over.

CAUSES: Major life events such as divorce, death of a loved one, or losing your job.

CHANCES OF BECOMING LONG-TERM DEPRESSION: Feeling this way after a major event is normal and the unhappiness should start to dissipate after several weeks.

But a single trauma can also be the straw that breaks the camel’s back if you have other things in your life that are causing agitation, such as stress at work. This can lead to long-term depression. If you’ve been down for several weeks with no improvement, seek help.

SOLUTION: Talking with friends, family or a counsellor is very important to give an outlet. Or see your GP about taking medication.

PHYSIOLOGICAL

SYMPTOMS: Fatigue, feeling weak, overwhelmed and exhausted even if you have had a good night’s sleep.

CAUSES: Health issues such as thyroid problems or symptoms relating to the menopause and ageing.

CHANCES OF BECOMING LONG-TERM DEPRESSION: This is a situation where health changes can affect mood, and therefore mimic depression. an under or overactive thyroid can, for example, produce symptoms that are very similar to depression, such as low spirits and excess fatigue.

SOLUTION: To rule out an underlying health problem, see your gp, who can carry out blood tests to see if a cause can be identified. Look at other factors in your life. For example, it’s natural to feel emotionally vulnerable after having a baby. If you still do a month after the birth, it could be depression.

STRESS-RELATED

SYMPTOMS: Feeling agitated, uptight and wound-up all the time, unable to focus or remember simple things. Finding even normal actions irritating. A constant feeling of being under pressure.

CAUSES: Taking on too much at work, moving house, caring for parents or children, relationship break-up.

CHANCES OF BECOMING LONG-TERM DEPRESSION: Stress is a normal part of life and there is research to suggest that limited amounts can be beneficial. However, cumulative stress can lead to long-term depression.

SOLUTION: If feelings persist for several weeks, or if you feel you can’t cope with them sooner than that, go to see your GP. Acknowledging the problem is part of the issue and may help identify what is triggering your stress. It will also be a chance to examine ways to relax and take on more exercise to help you cope with stress.

EXISTENTIAL

SYMPTOMS: You are tearful, restless and perhaps sleeping badly. nothing seems to give you any pleasure. There is also a sense of feeling you aren’t good at what you do.

CAUSES: Feeling rootless, directionless, empty or even trapped, as well as unsure of your place in the world. often triggered when between relationships or jobs.

CHANCES OF BECOMING LONG-TERM DEPRESSION: We all have phases when we feel negative and worthless, but if this goes on for more than two weeks, then such feelings can lead to chronic depression. Insomnia can worsen or you can suffer with hypersomnia – a desire to sleep all the time to avoid confronting reality.

SOLUTION: Counselling or psychotherapy will help you get to the root of your problem and feelings. If you lack motivation, or have low self-esteem, then CBT is helpful.

DYSTHYMIC

SYMPTOMS: Feeling burnt out, hopeless, as if nothing has any point. A feeling of being numb.

CAUSES: No particular trigger – many people say they feel born this way. They constantly feel negative and gloomy.

CHANCE OF BECOMING LONG-TERM DEPRESSION: People who feel this way say it has been going on since they were young, but it can get out of control. If you feel yourself having thoughts such as ‘I’d be better off dead’, seek help immediately.

SOLUTION: Cognitive behavioural therapy activates the mind to change thought processes and therefore patterns of behaviour. Sessions involve encouraging you to get out and do more for yourself and become more involved with other people. You will need a referral from your GP.

Read more: http://www.dailymail.co.uk/health/article-1290402/Lives-destroyed-happy-pills-As-use-antidepressants-DOUBLES-decade-experts-say-thousands-given-dangerous-drugs-dont-need.html#ixzz3LffqAaua
Follow us: @MailOnline on Twitter | DailyMail on Facebook

Posted in Psychiatric drugs problems | Tagged , , | Leave a comment